Clinical utility of natural killer cells in cancer therapy and transplantation.
about
Natural Killer Cells for Therapy of LeukemiaCord Blood as a Source of Natural Killer CellsSelection and expansion of natural killer cells for NK cell-based immunotherapyHarnessing adaptive natural killer cells in cancer immunotherapyEx vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.Activation-specific metabolic requirements for NK Cell IFN-γ production.Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.Natural killer cell therapy in children with relapsed leukemia.HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicityEffects of Systemically Administered Hydrocortisone on the Human Immunome.Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors.Transcription factor KLF2 regulates homeostatic NK cell proliferation and survival.The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer.Therapeutic potential and challenges of natural killer cells in treatment of solid tumorsNatural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.Role of NK cells in immunotherapy and virotherapy of solid tumors.The immune system and cancer evasion strategies: therapeutic concepts.In Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor Through Differentiation of Gene-Modified Hematopoietic Stem Cells.Harnessing NK Cell Memory for Cancer Immunotherapy.Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.In celebration of Ruggero Ceppellini: HLA in transplantation.Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation.Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell "missing self" recognition.CIS is a potent checkpoint in NK cell-mediated tumor immunity.Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients.Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell ActivitiesIL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors.Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell helpEmerging therapies for acute myeloid leukemia: translating biology into the clinic.Natural Killer Cells - Their Role in Tumour ImmunosurveillanceCirculating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia.Injectable Polymeric Cytokine-Binding Nanowires Are Effective Tissue-Specific Immunomodulators.Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2.Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.The Broad Spectrum of Human Natural Killer Cell Diversity.Anticancer cellular immunotherapies derived from umbilical cord blood.
P2860
Q26745906-05760B4F-953E-4FFA-981D-2B43BAF3CA66Q26771337-7C47BF18-DCFE-4FB0-A8A5-A72A331AAA71Q26774777-AF4F0859-29C7-4302-84A9-EF0928E13D6CQ28081448-96A2F56C-73E2-4976-A479-32075A57FCA4Q33861833-BBBE6D6A-1722-4021-BEFA-BCF5505D7F95Q35071267-E80D6F59-A0B1-4AA0-92B9-91933EB6F432Q35600095-7EDF2E5D-1D64-4BA2-B5C8-62B8D2F03CE4Q35803534-F3C0CE1D-46F6-42E3-9152-E1ACAA9B4A7DQ36187369-E72F75BE-B060-4770-AD9F-078939E20830Q36251948-BA15E568-77B1-492D-AB17-2769C7E4F56CQ36544773-9499DA1F-9039-42DB-AB83-4ACE6D22F186Q36681995-01B7F51C-66F9-4D03-BACA-68B573A6B594Q36781992-F86756BA-5563-4ECB-857C-85D3A5CEE471Q36799788-243BED6B-9ADB-4A12-B07A-D05BAD45E045Q36905050-5A817650-171B-443D-BA49-2746C5779D7BQ37517482-042C28DF-28D1-48F2-AEA4-AF797025DA64Q37590606-F917380D-AF77-430E-B4B8-07747699C85BQ38478878-4263010E-27F8-47F1-872C-1F4A009D717AQ38542034-749B23CF-DE7F-4EF8-B394-9CF486896C79Q38575116-0FC2E5D5-0A4B-4867-BDAF-FE119E0CAEF1Q38691172-B85B0C00-3A0D-44A9-B54C-C7FD506B5F64Q38771094-13CBE6B9-588E-45DE-BF61-98852796379FQ38988913-B082646E-63E1-4FAE-9AA3-3D13BD6E8F9AQ39037708-2EF058FB-C38F-4D28-979A-341B7C43559CQ39094693-5FFE85E2-A6DC-441B-B51F-7CF6425E6DB9Q39162642-49B2DD70-2921-4646-9168-848D110C3209Q39429911-786A1F02-0678-425E-ACB9-204A3B9553B9Q39744193-6B3E37F6-0722-4856-A4A7-9558B260959EQ39834269-562EE446-687B-4B05-82F2-2A48DF03B33FQ40693797-F7A26623-5047-4492-8156-CE7C1C480FB1Q41109227-E6CB2A80-1EEF-4A1B-84B7-CC3D158596E5Q41298261-6CBDF215-1A54-4EA0-9CE9-B88A339FA8AAQ41984963-C92FCEDE-F19C-4717-89E8-F30111D99E5CQ42282419-E13FCF63-EA04-48FB-B7CC-4B01833542D0Q46279219-AB716298-CABB-4ACB-8B17-A556EFD37731Q46445128-E05D0195-8DEA-4154-BD61-D82A76BE91C3Q47117842-0392F63F-2735-411E-BC0C-547A0D057B05Q47164846-8CD2C862-4E80-4C6B-A8EC-9469F8952B74Q47373461-0E8F8566-1276-475E-A0B2-34A1F8F0437AQ47657491-7DF5AAC4-5F29-4DBC-A91D-9EC834D6E5C9
P2860
Clinical utility of natural killer cells in cancer therapy and transplantation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical utility of natural killer cells in cancer therapy and transplantation.
@en
type
label
Clinical utility of natural killer cells in cancer therapy and transplantation.
@en
prefLabel
Clinical utility of natural killer cells in cancer therapy and transplantation.
@en
P2860
P1476
Clinical utility of natural killer cells in cancer therapy and transplantation.
@en
P2093
David A Knorr
Michael R Verneris
P2860
P304
P356
10.1016/J.SMIM.2014.02.002
P577
2014-03-05T00:00:00Z